Detalhe da pesquisa
1.
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results.
Ann Oncol
; 29(1): 133-138, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045659
2.
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results.
Ann Oncol
; 29(11): 2270, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29718089
3.
Evaluation of the relevance of the growth modulation index (GMI) from the FFCD 0307 randomized phase III trial comparing the sequence of two chemotherapeutic regimens.
ESMO Open
; 8(4): 101616, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37542912
4.
Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer.
Eur J Cancer
; 97: 16-24, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29777975
5.
[A comparison of serum Cyfra 21-1 and SCC AG in the diagnosis of squamous cell esophageal carcinoma]. / Evaluation comparative du Cyfra 21-1 et du squamous cell carcinoma dans les carcinomes épidermoïdes de l'oesophage.
Bull Cancer
; 88(10): 1023-7, 2001 Oct.
Artigo
em Francês
| MEDLINE | ID: mdl-11713038